Portrait of Johannes Kratz
ucsf logo

Johannes Kratz, MD

Thoracic Surgery • Thoracic Surgical OncologyChief, Division of Thoracic Surgery
Thoracic Surgery & Oncology Mount Zion
415-885-3882
Portrait of Johannes Kratz
Portrait of Johannes Kratz
ucsf logo

Johannes Kratz, MD

Thoracic Surgery • Thoracic Surgical OncologyChief, Division of Thoracic Surgery
Thoracic Surgery & Oncology Mount Zion
415-885-3882

On this page

About me

Dr. Johannes Kratz is a thoracic surgeon who specializes in treating disorders of the trachea, chest wall, lung, esophagus and mediastinum (the space between the lungs containing the heart and other structures). He directs UCSF's program for advanced minimally invasive thoracic surgery.

Kratz's research interests include robotic surgery outcomes, lung and esophageal cancers, biomarkers to personalize lung cancer treatment and immunotherapies for thoracic tumors. His current research focuses on understanding the molecular and genetic profiles of high-risk tumors in early stages and developing targeted therapies to treat them.

While a surgical research fellow at the UCSF Thoracic Oncology Laboratory, Kratz developed a test that more accurately predicts outcomes for patients with early-stage lung cancer. Now available to patients, this test has improved outcomes for those with high-risk lung cancer detected early.

Kratz earned his medical degree at Harvard Medical School, graduating magna cum laude. He completed a general surgery residency at Massachusetts General Hospital, followed by a fellowship in cardiothoracic surgery at UCSF. He also has a master's degree in philosophy from Stanford University.

Kratz is a member of the American College of Surgeons, Society of Thoracic Surgeons, Massachusetts Medical Society and American Society of Clinical Oncology. In 2017, he received a UCSF Health Exceptional Physician Award. He is the Van Auken Endowed Chair in Thoracic Oncology at UCSF.

Education & training

Board certification

  • Thoracic and Cardiac Surgery, American Board of Thoracic Surgery
  • General Surgery, American Board of Surgery

Fellowship

  • Cardiothoracic Surgery, UCSF Medical Center GME/RESEARCH
  • University of Alabama School of Medicine - GME

Residency

  • General Surgery, Massachusetts General Hospital GME

Internship

  • General Surgery, Massachusetts General Hospital GME

Degree

  • MD, Harvard Medical School

My expertise

Locations

    My work

    Improving patient outcomes

    Dr. Kratz explains why robot-assisted surgery is being used for more types of procedures and how it speeds up recovery.

    Reviews

    Average rating

    4.9
    4.9 out of 5 Stars
    153 ratings
    About provider reviews

    Showing 1-6 of 28 reviews

    Sort by
    • 5 out of 5 Stars
      October 30, 2025

      We are very pleased really with all aspects of care there.

    • 5 out of 5 Stars
      October 29, 2025

      Dr J Kratz is the best

    • 5 out of 5 Stars
      September 16, 2025

      Provider was very thoughtful and clear

    • 5 out of 5 Stars
      September 16, 2025

      Dr Kratz is the ideal.

    • 5 out of 5 Stars
      August 23, 2025

      Dr Kratz was amazing. Clearly very competent and experienced yet very humble and pleasant and patient with me. I had a really great medical visit with him and his team.

    • 5 out of 5 Stars
      July 30, 2025

      Dr. Kratz is an outstanding clinician-warm, empathetic, and knowledgeable. He had reviewed my case carefully prior to our videoconference and in his discussion anticipated all of my questions. I feel that I will be in the best of hands when I undergo the planned robot-assisted thoracic surgery.

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.